| 1 | VIP, VIPR1, VIPR2
|
| Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.
|
| Valdehita A, Bajo AM, Fernández-Martínez AB, Arenas MI, Vacas E, Valenzuela P, Ruíz-Villaespesa A, Prieto JC, Carmena MJ.
|
| Peptides 31(11):2035-45. Epub 2010 Aug 5.
2010
|
| 2 | VIP, VIPR1, VIPR2
|
| Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
|
| St Hilaire RC, Murthy SN, Kadowitz PJ, Jeter JR Jr.
|
| Peptides 31(8):1517-22. Epub 2010 May 7.
2010
|
| 3 | ADCYAP1R1, VIP, VIPR1, VIPR2
|
| VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.
|
| Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM.
|
| J Appl Physiol 109(1):95-100. Epub 2010 Apr 15.
2010
|
| 4 | VIP, VIPR1, VIPR2
|
| Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.
|
| Martin B, Shin YK, White CM, Ji S, Kim W, Carlson OD, Napora JK, Chadwick W, Chapter M, Waschek JA, Mattson MP, Maudsley S, Egan JM.
|
| Diabetes 59(5):1143-52. Epub 2010 Feb 11.
2010
|
| 5 | VIP, VIPR1, VIPR2
|
| Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
|
| Burian B, Storka A, Marzluf BA, Yen YC, Lambers C, Robibaro B, Vonbank K, Mosgoeller W, Petkov V.
|
| Peptides 31(4):603-8. Epub 2009 Dec 22.
2010
|
| 6 | VIP, VIPR1, VIPR2
|
| The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.
|
| Zaben M, Sheward WJ, Shtaya A, Abbosh C, Harmar AJ, Pringle AK, Gray WP.
|
| Stem Cells 27(10):2539-51.
2009
|
| 7 | VIPR1, VIPR2
|
| Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.
|
| Igarashi H, Ito T, Kuwano-Kojima M, Takayanagi R, Coy DH, Jensen RT.
|
| Pancreas 37(2):236-8. No abstract available.
2008
|
| 8 | VIP, VIPR1, VIPR2
|
| Select cognitive deficits in vasoactive intestinal peptide deficient mice.
|
| Chaudhury D, Loh DH, Dragich JM, Hagopian A, Colwell CS.
|
| BMC Neurosci 9:63.
2008
|
| 9 | VIPR1
|
| The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.
|
| Couvineau A, Tan YV, Ceraudo E, Lacapere JJ, Murail S, Neumann JM, Laburthe M.
|
| Ann N Y Acad Sci 1070:205-9. 2006
|
| 10 | VIPR1, VIPR2
|
| Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors.
|
| Bokaei PB, Ma XZ, Byczynski B, Keller J, Sakac D, Fahim S, Branch DR.
|
| Genomics 88(6):791-800. Epub 2006 Aug 24. 2006
|
| 11 | VIPR1, NR1H4
|
| VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
|
| Chignard N, Mergey M, Barbu V, Finzi L, Tiret E, Paul A, Housset C.
|
| Hepatology 42(3):549-57. 2005
|
| 12 | VIPR1, IKZF1
|
| Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros.
|
| Dorsam G, Goetzl EJ.
|
| J Biol Chem 277(16):13488-93. 2002
|
| 13 | VIP, VIPR1
|
| Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor.
|
| Rameshwar P, Gascon P, Oh HS, Denny TN, Zhu G, Ganea D.
|
| Exp Hematol 30(9):1001-9. 2002
|
| 14 | VIPR1
|
| The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
|
| Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M.
|
| Biochem J 347 Pt 3:623-32. 2000
|
| 15 | VIPR1
|
| Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene.
|
| Sreedharan SP, et al.
|
| Proc Natl Acad Sci U S A 92 : 2939-2943. 1995
|
| 16 | VIPR1
|
| Cloning and expression of the human vasoactive intestinal peptide receptor.
|
| Sreedharan SP, et al.
|
| Proc Natl Acad Sci U S A 88 : 4986-4990. 1991
|